Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-25-011136

Chief R&D Officer gave up 7,525 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Thackray Helen M. · Chief R&D Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-31 Shares withheld for taxes : show line 1 in the form −7,525 $7.50 $56,438 377,318 D
Loading xslF345X05/form4.xml…